FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing unit.

Rehaan Healthcare, which manufactures digestive syrup, multi-vitamin syrup and other syrup-based food products, has been asked to stop production till it corrects all deficiencies and the rectification gets verified by the competent authority.

FSSAI, during the inspection, found the manufacturing unit in unhygienic condition with poor infrastructure and other basic facilities, posing a serious health risk.

The regulator warned that legal action will be initiated if the Mohali-based company violates this order.

In a social media post on Friday, the Food Safety and Standards Authority of India (FSSAI) informed, “The license of Rehaan Healthcare has been suspended following serious non-compliance observed during the inspection of its health supplements and nutraceuticals manufacturing unit.”

The regulator has asked the company to immediately cease all food business activities until deficiencies are rectified and the same gets verified by the competent authority.

FSSAI pointed out that the manufacturing units got an overall compliance score of 12 per cent. The low score indicates “very serious failure and non-compliance of existing provisions”.

The regulator pointed out that manufacturing premises were extremely unhygienic and unorganised.

“Sediments of filth and sludge accumulated under the manufacturing tank, disorganised storage of raw materials and poor housekeeping created a serious risk of cross-contamination,” it added.

FSSAI also found major deficiencies in infrastructure and facilities.

These included inadequate storage arrangements, insufficient workspace, poor ventilation and lighting, damaged infrastructure, pest infestation and the absence of a valid drinking water test report.

“As the unit manufactures health supplements and nutraceuticals, a high-risk category of food consumed by children and other vulnerable groups, the unhygienic conditions and failure of food safety controls pose a serious and imminent threat to public health,” FSSAI said.

Spider webs, mould growth, flies, insects and exposed food waste were observed within the manufacturing area, the regulator added.

In the last few months, FSSAI has cracked down on many energy drink and alcoholic beverage companies for misleading claims and labelling. It has also issued notices to many e-commerce platforms.

These actions are based on consumer complaints, suo motu cognizance and also regular enforcement activities of food safety officers.

Related Posts

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Pilibhit: A joint inquiry by the chief medical officer and city magistrate has found alleged statutory violations at several private diagnostic centres and nursing homes in Pilibhit district. A report…

Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

According to the ministry, the scheme has facilitated the establishment of domestic manufacturing capabilities for a range of high-end medical devices that were earlier predominantly imported. New Delhi: The Product…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

Arogya Manthan 2026 to launch new digital health and health assurance initiatives

Arogya Manthan 2026 to launch new digital health and health assurance initiatives

Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream

Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream